Market Size of Global Coagulation Analyzers Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
CAGR | 8.85 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Coagulation Analyzers Market Analysis
The coagulation analyzers market is expected to grow at a CAGR of around 8.85% over the forecast period, 2022-2027.
The COVID-19 pandemic has affected the economics and sectors of many different countries due to lockdowns, travel restrictions, and business closures. The outbreak of COVID-19 causes the global shutdown which compelled the manufacturers of coagulation analyzers to halt manufacturing and distribution. The COVID-19 pandemic had a huge impact on the coagulation analyzer market. According to a November 2021 study titled "Meta-analysis of coagulation parameters connected with sickness severity and bad prognosis of COVID-19," coagulation problems may be viewed as risk factors for the severity and mortality of COVID-19. In addition, according to a February 2022 update by the National Institutes of Health, the panel advises testing hospitalized COVID-19 patients for thromboembolic disease if they experience a sudden localized loss of peripheral perfusion or a quick decline in pulmonary, cardiac, or neurological function. Therefore, it is anticipated that these studies will boost COVID-19 patients' need for coagulation analyzers, fueling the market's growth.
Further, the global coagulant analyzer market is driven by the increasing prevalence of chronic blood disorders, rising geriatric population coupled with the increasing prevalence of chronic diseases, and increasing laboratory automation. The increasing prevalence of chronic blood disorders is a major factor driving the market's growth. One of the key aspects influencing the market under study is the rising frequency of chronic blood disorders, which will increase the demand for coagulation analyzers. The Global Hemophilia Care 2020 study states that there have been 393,658 bleeding disorders recognized and documented globally over time, including 241,535 cases of hemophilia, and 87,729 cases of von Willebrand disease, and 64,394 cases of other bleeding disorders. As a result, the adoption of coagulation analyzers will be greatly boosted by the rising number of patients with blood disorders. In the United States, there were approximately 21,250 new instances of chronic lymphocytic leukemia in 2021, according to reports from the American Cancer Society (CLL). By examining blood cells that have been altered by leukemia, the illness is identified. Therefore, it is thought that the increasing number prevalence linked to chronic lymphocytic leukemia would increase the demand for coagulation tests, which will then propel market expansion. Product launches are another key factor in market growth. For instance, in July 2020, Automated Blood Coagulation Analyzers CN-6500/CN-3500, a novel product in the hemostasis sector, were introduced by Sysmex Corporation. With just one instrument, the new product may be used to measure all of the blood coagulation testing criteria, including molecular indicators for blood coagulation. Thus, the abovementioned factors are likely to increase market growth.
However, the high cost of fully automated coagulation analyzers and the slow adoption of advanced hemostasis instruments in developing and underdeveloped economies are restraining the market's growth.
Coagulation Analyzers Industry Segmentation
As per the scope of this report, coagulation analyzers are used for detecting the presence of blood clots in the blood vessels. These analyzers measure coagulation pathway speed as well as thrombolin and thromboplastin levels in a few minutes. A coagulation analyzer system also has built-in quality control and security lockout protocols to ensure safe and secure use, as it is used on sensitive information about patients' health. The Coagulation Analyzers Market is segmented by Product (Analyzers (Clinical Laboratory Analyzers, and Point of Care Analyzers), and Consumables), By Test Type (Fibrinogen Testing, D-Dimer Testing, Platelet Function Tests and Other Coagulation Tests), Technology (Optical, Mechanical, Electrochemical, and Others), End-User (Hospitals, Diagnostic Centers and Others) and Geography (North America, Europe, Asia Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
By Product | ||||
| ||||
Consumables |
By Test Type | |
Fibrinogen Testing | |
D-Dimer Testing | |
Platelet Function Tests | |
Other Coagulation Tests |
By Technology | |
Optical Technology | |
Mechanical Technology | |
Electrochemical Technology | |
Others |
By End User | |
Hospitals | |
Diagnostic Centers | |
Others |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Global Coagulation Analyzers Market Size Summary
The coagulation analyzers market is poised for significant growth, driven by several key factors. The increasing prevalence of chronic blood disorders and a rising geriatric population are major contributors to the market's expansion. The demand for coagulation analyzers is further bolstered by the growing need for laboratory automation and the introduction of advanced products. The COVID-19 pandemic has also played a pivotal role in shaping the market, as studies linking coagulation issues to COVID-19 severity have heightened the need for these analyzers. Despite challenges such as high costs and slow adoption in developing regions, the market is expected to thrive, supported by ongoing product innovations and strategic initiatives by key industry players.
North America is anticipated to hold a significant share of the coagulation analyzers market, fueled by the high prevalence of chronic blood disorders and strategic industry developments. The region's market growth is further supported by efforts to enhance clinical laboratory infrastructure and early detection of blood abnormalities. The competitive landscape is characterized by the presence of major companies like F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, and Trivitron Healthcare, which are actively engaging in product innovation and strategic partnerships to maintain their market positions. The introduction of new products and the renewal of strategic agreements, such as those between Siemens Healthineers and Sysmex Corporation, are expected to drive the market forward, ensuring robust growth over the forecast period.
Global Coagulation Analyzers Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Prevalence of Chronic Blood Disorders
-
1.2.2 Rising Geriatric Population Coupled with Increasing Prevalence of Chronic Diseases
-
1.2.3 Increasing Laboratory Automation
-
-
1.3 Market Restraints
-
1.3.1 Slow Adoption Rate in Underdeveloped Economies
-
1.3.2 High Cost of Test for Fully Automated Analyzers
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Product
-
2.1.1 Analyzers
-
2.1.1.1 Clinical Laboratory Analyzers
-
2.1.1.2 Point of Care Analyzers
-
-
2.1.2 Consumables
-
-
2.2 By Test Type
-
2.2.1 Fibrinogen Testing
-
2.2.2 D-Dimer Testing
-
2.2.3 Platelet Function Tests
-
2.2.4 Other Coagulation Tests
-
-
2.3 By Technology
-
2.3.1 Optical Technology
-
2.3.2 Mechanical Technology
-
2.3.3 Electrochemical Technology
-
2.3.4 Others
-
-
2.4 By End User
-
2.4.1 Hospitals
-
2.4.2 Diagnostic Centers
-
2.4.3 Others
-
-
2.5 Geography
-
2.5.1 North America
-
2.5.1.1 United States
-
2.5.1.2 Canada
-
2.5.1.3 Mexico
-
-
2.5.2 Europe
-
2.5.2.1 Germany
-
2.5.2.2 United Kingdom
-
2.5.2.3 France
-
2.5.2.4 Italy
-
2.5.2.5 Spain
-
2.5.2.6 Rest of Europe
-
-
2.5.3 Asia-Pacific
-
2.5.3.1 China
-
2.5.3.2 Japan
-
2.5.3.3 India
-
2.5.3.4 Australia
-
2.5.3.5 South Korea
-
2.5.3.6 Rest of Asia-Pacific
-
-
2.5.4 Middle East and Africa
-
2.5.4.1 GCC
-
2.5.4.2 South Africa
-
2.5.4.3 Rest of Middle East and Africa
-
-
2.5.5 South America
-
2.5.5.1 Brazil
-
2.5.5.2 Argentina
-
2.5.5.3 Rest of South America
-
-
-
Global Coagulation Analyzers Market Size FAQs
What is the current Global Coagulation Analyzers Market size?
The Global Coagulation Analyzers Market is projected to register a CAGR of 8.85% during the forecast period (2024-2029)
Who are the key players in Global Coagulation Analyzers Market?
F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Helena Laboratories, Meril Life Sciences Pvt. Ltd. and Trivitron Healthcare are the major companies operating in the Global Coagulation Analyzers Market.